reports
Ensari Deri Gida Sanayi Ve Ticaret A S: 1 director
A director at Ensari Deri Gida Sanayi Ve Ticaret A S sold 4,400,000 shares at 30.780TRY and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Salesforce Inc: 4 directors
A director at Salesforce Inc sold after exercising options 5,864 shares at 274.773USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Cencora Inc: 2 directors
A director at Cencora Inc sold/sold after exercising options 57,564 shares at 235.090USD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
Belysse Group N.V.: 1 director
A director at Belysse Group N.V. bought 35,786 shares at 0.920EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Coop Pank unaudited financial results for Q1 2024
Coop Pank unaudited financial results for Q1 2024 By the end of the Q1 2024, Coop Pank had 189,000 customers, increased by 7,000 customers in the quarter (+4%) and by 34,000 in the year (+22%). The bank had 84,400 active customers, increased by 2,400 (+3%) in the quarter and by 14,300 (+20%) in the year. In Q1 2024, volume of deposits in Coop Pank decreased by 29 million euros (-2%), reaching total of 1.69 billion euros. Deposits from private clients increasing by 11 million euros: demand deposits increased by 8 million euros and term deposits increased by 3 million euros. Deposits from d...
Coop Pank 2024. aasta I kvartali auditeerimata majandustulemused
Coop Pank 2024. aasta I kvartali auditeerimata majandustulemused 2024. aasta I kvartali lõpu seisuga oli Coop Pangal 189 000 klienti, klientide arv kasvas kvartaliga 7000 kliendi võrra (+4%) ja aastaga 34 000 võrra (+22%). Aktiivselt arveldavaid kliente oli 84 400, kvartaliga kasvas aktiivselt arveldavate klientide arv 2400 võrra (+3%) ja aastaga 14 300 (+20%). Coop Panga hoiuste maht kahanes 2024. aasta I kvartalis 29 miljoni euro võrra (-2%), ulatudes 1,69 miljardi euroni. Eraklientide hoiuste portfell kasvas 11 miljoni euro võrra: nõudmiseni hoiused kasvasid 8 miljoni euro võrra ja tä...
Aspocomp’s Interim Report January 1 – March 31, 2024: Net sales and op...
Aspocomp’s Interim Report January 1 – March 31, 2024: Net sales and operating result decreased from the comparison period Aspocomp Group Plc, Interim Report, April 18, 2024, at 8:00 a.m. (Finnish time) FIRST QUARTER 2024 HIGHLIGHTS Net sales EUR 6.2 (8.9) million, decrease of 30%Operating result EUR -1.6 (0.3) million, -25.9% (3.8%) of net salesEarnings per share EUR -0.24 (0.04)Operative cash flow EUR -2.0 (1.6) millionOrders received EUR 7.5 (13.7) million, decrease of 45%Order book at the end of the review period EUR 11.8 (19.1) million, decrease of 38%Equity ratio 64.5% (72.9%) ...
Aspocompin osavuosikatsaus 1.1-31.3.2024: Liikevaihto ja liiketulos la...
Aspocompin osavuosikatsaus 1.1-31.3.2024: Liikevaihto ja liiketulos laskivat vertailukaudesta Aspocomp Group Oyj, Osavuosikatsaus, 18.4.2024 klo 8.00 ENSIMMÄINEN NELJÄNNES 2024 LYHYESTI Liikevaihto 6,2 (8,9) miljoonaa euroa, laskua 30 %Liiketulos -1,6 (0,3) miljoonaa euroa, -25,9 (3,8) % liikevaihdostaOsakekohtainen tulos -0,24 (0,04) euroaLiiketoiminnan rahavirta -2,0 (1,6) miljoonaa euroaSaadut tilaukset 7,5 (13,7) miljoonaa euroa, laskua 45 %Tilauskanta katsauskauden lopussa 11,8 (19,1) miljoonaa euroa, laskua 38 %Omavaraisuusaste 64,5 (72,9) % NÄKYMÄT VUODELLE 2024 Inflaat...
Nokia Corporation Interim Report for Q1 2024
Nokia Corporation Interim Report for Q1 2024 Nokia CorporationInterim report18 April 2024 at 08:00 EEST Nokia Corporation Interim Report for Q1 2024 Strong cash flow and improving orders despite market weakness As expected, a slow start to 2024 with net sales declining 19% y-o-y in constant currency (-20% reported) in Q1.Environment still challenging but order trends continue to improve year-on-year, particularly in Network Infrastructure.Comparable gross margin in Q1 increased by 1 090bps y-o-y to 48.6% (reported increased 1 040bps to 47.9%). Strong contribution from Nokia Technologies ...
Nokia Oyj:n vuoden 2024 ensimmäisen neljänneksen osavuosikatsaus
Nokia Oyj:n vuoden 2024 ensimmäisen neljänneksen osavuosikatsaus Nokia OyjOsavuosikatsaus 18.4.2024 klo 8.00 Nokia Oyj:n vuoden 2024 ensimmäisen neljänneksen osavuosikatsaus Kassavirta oli vahva ja tilaukset kasvoivat heikosta markkinatilanteesta huolimatta Kuten ennakoimme, vuosi käynnistyi verkkaisesti ja ensimmäisen neljänneksen liikevaihto laski 19 % edellisvuodesta ilman valuuttakurssimuutosten vaikutusta (raportoitu -20 %).Toimintaympäristö pysyi haastavana, mutta tilaukset jatkoivat kasvua edellisvuoteen verrattuna erityisesti Verkkoinfrastruktuuri-liiketoimintaryhmässä.Vertailuke...
Addex Therapeutics Reports Full Year 2023 Financial Results and Provid...
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update Top-line data from ADX71149 Phase 2 epilepsy study expected by mid-May 2024Launched Neurosterix with Perceptive Advisors, raising USD 63 million in Series A to accelerate development of preclinical portfolio Received CHF 5 million upfront and 20% equity in Neurosterix, providing cash runway beyond 2026 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 18, 2024 - (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug...
Planned Changes in the Management Boards of LHV Group and LHV Pank
Planned Changes in the Management Boards of LHV Group and LHV Pank The Supervisory Board of AS LHV Group has decided to recall the Management Board member and CRO Martti Singi by the end of 2024 at the latest as mutually agreed. Simultaneously, it has been decided to recall the Management Board member and CRO of AS LHV Pank within the same timeframe. According to Madis Toomsalu, Chairman of the Management Board of LHV Group, Martti Singi’s contribution to risk management at LHV has been significant. “Martti has been one of the main constructors of LHV’s current risk management. He has done...
BioSenic S.A. : Transparency notifications received from François Rie...
BioSenic S.A. : Transparency notifications received from François Rieger PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, April 18, 2024, 7am CET – (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it has received transparency notifications from François Rieger. Details of the notifications can be found below and the full versions of the transparency declarations are available ...
BioSenic S.A. : Notifications de transparence reçues de la part de Fr...
BioSenic S.A. : Notifications de transparence reçues de la part de François Rieger COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 18 avril 2024 à 7h00 CET – (Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée dans les maladies auto-immunes et inflammatoires graves et dans la thérapie cellulaire, annonce aujourd’hui la réception de notifications de transparence de François Rieger. Les détails des notifications peuvent être trou...
Plaanitav muudatus LHV Groupi ja LHV Panga juhatuses
Plaanitav muudatus LHV Groupi ja LHV Panga juhatuses AS-i LHV Group nõukogu otsustas tagasi kutsuda juhatuse liikme, riskijuhi Martti Singi vastavalt kokkuleppele hiljemalt 2024. aasta lõpus. Ühtlasi otsustati samas ajaraamis kutsuda Martti Singi tagasi ka AS-i LHV Pank juhatuse liikme ja riskijuhi kohalt. LHV Groupi juhatuse esimees Madis Toomsalu ütles, et Martti Singi panus LHV riskijuhtimisse on olnud märkimisväärne. „Martti on olnud LHV senise riskijuhtimise üks peamiseid ülesehitajaid. Seejuures teinud seda efektiivselt ja meie kasvuambitsioonidega arvestavalt. LHV on tootluse osas...
- Felix Fischer
Lucror Analytics - Convertibles Brief
Lucror Analytics Convertibles Briefs comprise fundamental credit analysis, opinions and trade recommendations on convertible bond issuers, based on key company-specific developments in the past 24 hours. The publication includes a section with a brief market commentary, key market indicators, and a corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
- ABGSC Capital Goods Research
- Anders Idborg
- Olof Cederholm
- Felix Fischer
Lucror Analytics - Morning Views Europe
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
Mowi ASA (OSE:MOWI): Q1 2024 Trading update
Mowi ASA (OSE:MOWI): Q1 2024 Trading update Harvest volumes Q1 2024 (1) Farming Norway55.0 thousand tonnesFarming Scotland14.5 thousand tonnesFarming Chile12.5 thousand tonnesFarming Canada8.5 thousand tonnesFarming Ireland1.0 thousand tonnesFarming Faroes2.5 thousand tonnesFarming Iceland (Arctic Fish)2.5 thousand tonnesTotal96.5 thousand tonnes Note:(1) The harvest volumes are provided in gutted weight equivalents (GWE). Additional information Operational EBIT for the Group was approximately EUR 201 million in Q1 2024. Blended farming cost was EUR 6.05 per kg in the quarter. Issues w...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.